Petition Filed

No. 21-1566

Juno Therapeutics, Inc., et al. v. Kite Pharma, Inc.

from the United States Court of Appeals for the Federal Circuit

See other cases from the Federal Circuit.

Docket Entries

Motion to extend the time to file a response is granted and the time is extended to and including August 24, 2022.

Motion to extend the time to file a response from July 15, 2022 to August 24, 2022, submitted to The Clerk.

Petition for a writ of certiorari filed. (Response due July 15, 2022)

Application (21A461) granted by The Chief Justice extending the time to file until June 13, 2022.

Application (21A461) to extend the time to file a petition for a writ of certiorari from April 14, 2022 to June 13, 2022, submitted to The Chief Justice.


Juno Therapeutics, Inc., et al., Petitioner, represented by Gregory Andrew Castanias

Kite Pharma, Inc., Respondent, represented by E. Joshua Rosenkranz

Amici Curiae

Amgen Inc., Association of University Technology Managers (AUTM), Instil Bio, Inc., Corning Incorporated, Bavarian Nordic A/S, and GlaxoSmithKline plc, Amicus Curiae, represented by Jeffrey Alan Lamken

City of Hope, Amicus Curiae, represented by Daralyn Jeannine Durie

Mark D. Janis and Timothy R. Holbrook, Amicus Curiae, represented by Timothy R. Holbrook

REGENXBIO Inc., Amicus Curiae, represented by Matthew James Dowd

St. Jude Children’s Research Hospital, Inc., Albert Einstein College of Medicine, the University of Texas MD Anderson Cancer Center, and Other Academic Research Institutions, Amicus Curiae, represented by Vanessa Y. Yen

Last updated: August 17, 2022